High-Risk Early Breast Cancer in Patients Under 40 Years of Age: Improved Clinical Outcome With Total Estrogen Blockade and Tailored Chemotherapy

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2010.135
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

High-Dose Chemotherapy in High-Risk Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2000English

Acute Diverticulitis in Patients Under 40 Years of Age: Radiologic Diagnosis

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1988English

Clinical Breast Cancer and Estrogen

Breast Cancer Research
Cancer ResearchOncology
2003English

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2013English

Performance of BCRAT in High-Risk Patients With Breast Cancer

The Lancet Oncology
Oncology
2019English

Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Roles and Mechanisms of Estrogen and Estrogen Receptors in Breast Cancer Resistant to Chemotherapy

2011English

Age of 40 Years or Younger Is an Independent Risk Factor for Locoregional Failure in Early Breast Cancer: A Single-Institutional Analysis in Saudi Arabia

Journal of Oncology
Oncology
2012English

Retinopathy at Diagnosis of Diabetes, With Special Reference to Patients Under 40 Years of Age

BMJ
1969English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy